Physician profile
Justin L Groce
NPI 1013386929
$4,018.97
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,353 · 2022: $1,599 · 2023: $38.83 · 2024: $28.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $884.50 | 2021-2024 | |
| Novo Nordisk INC | $629.32 | 2021-2022 | |
| Mannkind Corporation | $424.29 | 2021-2022 | |
| Amgen INC. | $369.30 | 2021-2022 | |
| Lilly USA, LLC | $228.66 | 2021-2022 | |
| Glaxosmithkline, LLC. | $149.85 | 2021-2022 | |
| Corcept Therapeutics | $118.48 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $114.81 | 2021-2022 | |
| Esperion Therapeutics, INC. | $89.40 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $77.95 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $73.04 | 2021-2022 | |
| Amarin Pharma, INC. | $71.62 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $69.29 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.70 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.47 | 2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $42.68 | 2022-2024 | Proclaim |
| Takeda Pharmaceuticals U.S.A., INC. | $40.24 | 2021-2022 | |
| Pfizer INC. | $38.14 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $38.07 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $32.86 | 2021 | |
| Nestle Healthcare Nutrition INC. | $32.81 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $32.58 | 2021 | |
| Lundbeck LLC | $31.17 | 2021-2022 | |
| Antares Pharma, INC. | $30.57 | 2022 | |
| Allergan, INC. | $29.42 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $28.36 | 2021 | |
| Clarus Therapeutics INC. | $27.82 | 2021 | |
| Adlon Therapeutics L.P. | $25.23 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.71 | 2022 | |
| Astellas Pharma US INC | $18.01 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.06 | 2022 | |
| Horizon Therapeutics Plc | $15.53 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.36 | 2022 | |
| Medtronic, INC. | $14.82 | 2022 | |
| Alfasigma USA, INC. | $14.75 | 2022 | |
| Philips North America LLC | $12.76 | 2022 | |
| Merck Sharp & Dohme LLC | $12.26 | 2021 | |
| Radius Health, INC. | $11.55 | 2021 | |
| Tandem Diabetes Care, INC. | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Groce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.